A Multiple Oral Doses Study Of PF-06427878 In Healthy Adult Subjects
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
PF-06427878 is a new compound proposed for the treatment of hyperlipidemia. The primary
purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of
multiple oral doses of PF-06427878 in healthy adult subjects.